To continue or discontinue antidepressants in anxiety disorders? A dilemma for patients and clinicians

To continue or discontinue antidepressants in anxiety disorders? A dilemma for patients and clinicians

J Psychiatry Neurosci 2021;46(3):E388-E389 | PDF

Anna Muntingh, PhD; Neeltje Batelaan, MD, PhD; Willemijn Scholten, PhD, Anton J. van Balkom, MD, PhD


Affiliations: From the Amsterdam UMC, VU University, Psychiatry, Amsterdam Public Health research institute, The Netherlands (Muntingh, Batelaan, Scholten, Van Balkom); and the GGZ inGeest Specialized Mental Health Care, Amsterdam, The Netherlands (Muntingh, Batelaan, Scholten, Van Balkom).

Competing interests: None declared.

Content licence: This is an Open Access article distributed in accordance with the terms of the Creative Commons Attribution (CC BY-NC-ND 4.0) licence, which permits use, distribution and reproduction in any medium, provided that the original publication is properly cited, the use is non-commercial (i.e. research or educational use), and no modifications or adaptations are made. See: https://creativecommons.org/licenses/by-nc-nd/4.0/

DOI: 10.1503/jpn.200099